Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M384Revenue (TTM) $M356Net Margin (%)49.0Altman Z-Score2.8
Enterprise Value $M434EPS (TTM) $1.1Operating Margin %83.9Piotroski F-Score3
P/E(ttm)2.2Beneish M-Score-3.1Pre-tax Margin (%)80.6Higher ROA y-yN
Price/Book0.510-y EBITDA Growth Rate %19.7Quick Ratio2.9Cash flow > EarningsN
Price/Sales1.15-y EBITDA Growth Rate %23.0Current Ratio2.9Lower Leverage y-yY
Price/Free Cash Flow2.4y-y EBITDA Growth Rate %-34.6ROA % (ttm)16.3Higher Current Ratio y-yN
Dividend Yield %4.3PEG0.1ROE % (ttm)24.8Less Shares Outstanding y-yN
Payout Ratio %24.0Shares Outstanding M166ROIC % (ttm)24.1Gross Margin Increase y-yN

Gurus Latest Trades with PDLI

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
PDLIJoel Greenblatt 2016-09-30 Reduce-0.04%$2.72 - $3.57
($3.17)
$ 2.32-27%Reduce -44.80%1,266,121
PDLIBarrow, Hanley, Mewhinney & Strauss 2016-09-30 Add$2.72 - $3.57
($3.17)
$ 2.32-27%Add 0.71%299,285
PDLIJoel Greenblatt 2016-06-30 Reduce-0.05%$2.95 - $3.82
($3.33)
$ 2.32-30%Reduce -38.56%2,293,523
PDLIBarrow, Hanley, Mewhinney & Strauss 2016-06-30 Reduce$2.95 - $3.82
($3.33)
$ 2.32-30%Reduce -0.36%297,175
PDLIJoel Greenblatt 2016-03-31 Reduce-0.04%$2.75 - $3.54
($3.12)
$ 2.32-26%Reduce -21.40%3,732,679
PDLIBarrow, Hanley, Mewhinney & Strauss 2016-03-31 Add$2.75 - $3.54
($3.12)
$ 2.32-26%Add 5.86%298,243
PDLIJoel Greenblatt 2015-12-31 Reduce-0.01%$3.5 - $5.26
($4.16)
$ 2.32-44%Reduce -5.90%4,748,690
PDLIBarrow, Hanley, Mewhinney & Strauss 2015-12-31 Add$3.5 - $5.26
($4.16)
$ 2.32-44%Add 1.90%281,746
PDLIJoel Greenblatt 2015-09-30 Reduce-0.12%$4.95 - $6.56
($5.73)
$ 2.32-60%Reduce -30.24%5,046,353
PDLIJoel Greenblatt 2015-06-30 Add0.21%$6.23 - $7.3
($6.7)
$ 2.32-65%Add 114.94%7,233,838
PDLIBarrow, Hanley, Mewhinney & Strauss 2015-06-30 Add$6.23 - $7.3
($6.7)
$ 2.32-65%Add 5.41%276,491
PDLIJoel Greenblatt 2015-03-31 Add0.17%$6.7 - $7.72
($7.24)
$ 2.32-68%Add 1739.03%3,365,474
PDLIBarrow, Hanley, Mewhinney & Strauss 2015-03-31 Buy $6.7 - $7.72
($7.24)
$ 2.32-68%New holding262,299
PDLIJoel Greenblatt 2014-12-31 Add0.01%$7.325 - $8.53
($7.92)
$ 2.32-71%Add 603.94%183,003
PDLIJoel Greenblatt 2014-09-30 Reduce-0.09%$7.51 - $10.26
($9.3)
$ 2.32-75%Reduce -96.71%25,997
PDLIJoel Greenblatt 2014-06-30 Reduce-0.11%$8 - $9.85
($8.9)
$ 2.32-74%Reduce -52.58%789,804
PDLIJoel Greenblatt 2014-03-31 Reduce-0.34%$7.46 - $9.14
($8.57)
$ 2.32-73%Reduce -50.19%1,665,543
PDLIJoel Greenblatt 2013-09-30 Add0.15%$7.72 - $8.44
($8.04)
$ 2.32-71%Add 24.84%2,890,564
PDLIJoel Greenblatt 2013-03-31 Add0.15%$6.65 - $7.53
($7.08)
$ 2.32-67%Add 23.50%2,135,460
PDLIJoel Greenblatt 2012-12-31 Add0.59%$7.09 - $8.37
($7.75)
$ 2.32-70%Add 561.89%1,729,133
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

PDLI is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


PDLI: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
GARCIA PETER SVice President, CFO 2016-08-09Buy10,000$3-22.67view
GARCIA PETER SVice President, CFO 2015-12-15Buy15,000$3.5-33.71view
Pietzke SteffenController and CAO 2015-12-07Buy20,590$3.64-36.26view
GARCIA PETER SVice President, CFO 2015-08-14Buy20,000$5.83-60.21view
SELICK HAROLD EDirector 2014-11-26Buy6,000$8.08-71.29view
Lindell Jody SDirector 2011-03-15Buy374$5.33-56.47view
LARSON CHRISTINE RVice President and CFO 2010-05-14Buy5,000$5.71-59.37view
LARSON CHRISTINE RVice President and CFO 2010-04-30Buy10,000$6.18-62.46view
KLEIN JOSEPH IIIDirector 2009-11-04Sell24,000$8.33-72.15view
Lindell Jody SDirector 2009-06-15Buy3,000$7.76-70.1view

Press Releases about PDLI :

Quarterly/Annual Reports about PDLI:

News about PDLI:

Articles On GuruFocus.com
Medical Companies Offer Good Value Opportunities Sep 16 2016 
Undervalued Companies With Growing EPS Apr 04 2016 
Cash is Flowing Nicely for These Five Stocks Aug 19 2015 
Context Capital Management's Top Buys in Q2 2015 Jul 15 2015 
Weekly 3-Year Low Highlights: APOL, PDLI, TC, ALLT, ELRC May 17 2015 
Hot Picks with High Yields Jul 23 2013 
My 3 Favorite Healthcare Dividend Stocks with Highest Float Short Ratio Jun 03 2013 
My 4 Favorites From The 20 Cheapest Healthcare Dividend Stock List May 02 2013 
68 Top-Yielding Stocks with Ex-Dividend Date in March 2013 Feb 27 2013 
20 Best Yielding Healthcare Growth Stocks and Which to Buy Feb 02 2013 

More From Other Websites
ETFs with exposure to PDL BioPharma, Inc. : January 20, 2017 Jan 20 2017
Can PDL BioPharma Be a Top Choice for Value Investors? Jan 19 2017
PDL BIOPHARMA, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits Jan 09 2017
PDL BIOPHARMA, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events Dec 20 2016
[$$] Medical-Device Company Enters Chapter 11 Dec 19 2016
ETFs with exposure to PDL BioPharma, Inc. : December 19, 2016 Dec 19 2016
LENSAR® Strategic Restructure in Partnership with PDL BioPharma, Inc. Dec 19 2016
PDL BIOPHARMA, INC. Files SEC form 8-K, Change in Directors or Principal Officers Dec 16 2016
Is Vera Bradley, Inc. (VRA) Worthy of Your Portfolio? Dec 12 2016
Pace Holdings Corp (PACE): Hedge Fund Sentiment Unchanged Dec 08 2016
ETFs with exposure to PDL BioPharma, Inc. : December 5, 2016 Dec 05 2016
Is PDL BioPharma Inc (PDLI) Going to Burn These Hedge Funds? Dec 02 2016
Fitbit, Vodafone Sink into Tuesday’s 52-Week Low Club Nov 29 2016
PDL BIOPHARMA, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits Nov 29 2016
PDL BIOPHARMA, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a... Nov 28 2016
Vodafone, Towerstream Slide into Monday’s 52-Week Low Club Nov 28 2016
ETFs with exposure to PDL BioPharma, Inc. : November 23, 2016 Nov 23 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)